Berberine restrains the expansion of colorectal cancer organoids by blocking cell cycle progression and reducing lipid synthesis - Top-Institutions - MDSpire

Berberine restrains the expansion of colorectal cancer organoids by blocking cell cycle progression and reducing lipid synthesis

By
Hefei Tian
Tianshuo Zhao
Banghui Liu
Yujun Huang
Xi Wang
Zhenni Xu
Lingxiao Huang
Xudan Lei
Mingyue Qu
Qiongying Hu
Dengqun Liu
July 10, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
#2

Memorial Sloan Kettering Cancer Center

New York, New York
Key Differentiators
- Oncology
#3

Mayo Clinic Comprehensive Cancer Center

Rochester, Minnesota
Key Differentiators
- Oncology
#4

Hospital Clinic Barcelona

Barcelona, Spain
Key Differentiators
- Oncology
#5

Mount Sinai

New York, New York
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Immunology

Berberine restrains the expansion of colorectal cancer organoids by blocking cell cycle progression and reducing lipid synthesis

by Hefei Tian, Tianshuo Zhao, Banghui Liu, Yujun Huang, Xi Wang, Zhenni Xu, Lingxiao Huang, Xudan Lei, Mingyue Qu, Qiongying Hu, Dengqun Liu
July 10, 2026

Related Content

Frontiers In Immunology

Spatial transcriptomics reveals molecular differences associated with malignant transformation in oral epithelial dysplasia

by Naren Raja, Harsh B. Pathak, Amrita Mitra, Sufi Mary Thomas, Yong Wang, Tanya Marie Gibson, Rong Wang
July 10, 2026

Frontiers In Neurology

Machine and deep learning based on magnetic resonance imaging to segment glioblastoma and predict the spread of recurrence: a multicenter retrospective protocol

Frontiers In Digital Health

Translational AI in whole-slide image cancer histopathology: state of the art and regulatory-approved solutions